The global weight loss and obesity management market is set to experience remarkable expansion in the coming decade. With new projections forecasting a surge from an estimated USD 14,511 million in 2024 to an impressive USD 48,396 million by 2034, the market is expected to grow at a robust compound annual growth rate (CAGR) of 12.8%, reflecting the dynamic evolution of the sector.
This substantial growth is attributed to a combination of key factors, including a significant shift in consumer attitudes towards health and wellness, advancements in treatment options, and the growing prevalence of obesity worldwide. As the market evolves, innovative solutions and comprehensive weight management programs are expected to drive this upward trajectory.
Key Factors Driving Market Growth:
1. Rising Obesity Rates: The increasing global prevalence of obesity is fueling demand for effective weight loss solutions. With a growing number of individuals proactively seeking to manage their weight, the adoption of obesity management programs is experiencing a notable surge.
2. Technological Advancements: Innovations in technology, such as digital health solutions and advanced medical devices, are enhancing the effectiveness of weight loss treatments. These advancements are playing a pivotal role in improving the precision and efficiency of treatments, further propelling market growth.
3. Growing Awareness: Heightened awareness of the health risks associated with obesity is prompting individuals to invest in weight loss and obesity management solutions. As health-conscious consumers increasingly recognize the benefits of maintaining a healthy weight, the demand for effective solutions continues to rise.
4. Government Initiatives: Supportive government policies and initiatives aimed at combating obesity are creating a favorable environment for market growth. Programs that promote healthy lifestyles, preventive measures, and public health campaigns are expected to further bolster the industry.
A Market Poised for Sustained Growth
As the global weight loss and obesity management market continues to evolve, it is well-positioned for sustained growth. The combination of rising obesity rates, technological innovations, increased consumer awareness, and government initiatives is creating a vast landscape of opportunities for industry stakeholders and investors. With the market’s promising trajectory, the next decade is set to witness a transformative period in weight management, offering unparalleled potential for innovation and investment.
Get the Latest on Weight Loss and Obesity Management: Our Full Report Highlights Key Trends and Insights! https://www.einpresswire.com/article/730090938/weight-loss-and-obesity-management-market-is-expected-to-be-valued-at-usd-48-396-million-growing-at-a-12-8-cagr-by-2034-future-market-insights
Key Market Insights
- CAGR and Market Valuation: The global weight loss and obesity management market is projected to register a CAGR of 12.8% and achieve a valuation of USD 48,396 million by 2034.
- Dominant Segments: The drugs segment is expected to dominate the market, holding a 48.60% share in 2024. Additionally, the institution sales segment is anticipated to drive significant growth, capturing a 75.70% market share in 2024.
Market Dynamics and Competitive Landscape:
The market is characterized by intense competition, with numerous players offering a wide range of products and services, including weight loss programs, supplements, meal replacements, and fitness equipment. In addition to established companies, the market has seen the emergence of start-ups and niche players introducing innovative solutions to meet the growing demand for weight loss and obesity management.
Recent Developments
- Amgen Inc. (2021): Amgen disclosed the findings of a Phase 1 clinical trial involving AMG 133, a bispecific molecule designed as a GIPR antagonist and GLP-1 receptor agonist. The study focused on non-diabetic obese individuals and evaluated the molecule's safety, tolerability, and pharmacokinetic and pharmacodynamic properties.
- Novo Nordisk (2021): Novo Nordisk developed semaglutide, a weight-loss drug that has demonstrated the ability to enhance the physical function and overall well-being of obese individuals.
Key Market Players
Prominent players in the global weight loss and obesity management market include:
- Atkins Nutritionals, Inc.
- Ethicon US, LLC
- Herbalife Ltd.
- Nutrisystem, Inc.
- Weight Watchers International, Inc.
- Jenny Craig, Inc.
- Apollo Endosurgery, Inc.
- Brunswick Corporation
- Covidien plc
Market Segmentation
- By Product Type: Devices (Liposuction Devices, Bariatric Stapling Devices, Gastric Bands, etc.), Drugs (GLP-1 Receptor Agonists, Lipase Inhibitors, etc.)
- By Distribution Channel: Institutional Sales (Hospitals, Weight Loss Clinics), Retail Sales (Retail Pharmacies, Online Sales)
- By Region: North America, Latin America, East Asia, South Asia, Europe, Oceania, Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Comments
0 comment